Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Molls

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Cancer Treatment Reviews|May 23, 2006
Current status of angiogenesis inhibitors combined with radiation therapyCarsten Nieder, Nicole Wiedenmann, Nicolaus Andratschke, et al.
Anticancer Research|February 26, 2004
Radiotherapy-induced lung toxicity: risk factors and prevention strategiesCarsten Nieder, Branislav Jeremic, Sabrina Astner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breastsCarsten Nieder, Sabine Schill, Peter Kneschaurek, et al.
Cell Stress & Chaperones|August 31, 2012
Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levelsDaniela Schilling, Michael Düwel, Michael Molls, et al.
Anticancer Research|February 26, 2004
Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancerCarsten Nieder, Nicolaus Andratschke, Branislav Jeremic, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Necessity of identifying the patterns of failure after concurrent radiochemotherapy part of a combined modality approach in patients with stage III non-small cell lung cancer [Sakai et al., Lung Cancer 2004;43:195-201]Branislav Jeremic, Frank Zimmermann, Carsten Nieder, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
Validation of the graded prognostic assessment index for patients with brain metastasesCarsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of preventionNicolaus Andratschke, Jean Maurer, Michael Molls, et al.
Critical Reviews in Oncology/Hematology|August 1, 2006
Therapeutic options for recurrent high-grade glioma in adult patients: recent advancesCarsten Nieder, Markus Adam, Michael Molls, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Retreatment of the spinal cord with palliative radiotherapyAnca-Ligia Grosu, Nicolaus Andratschke, Carsten Nieder, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|May 23, 2006
Current status of angiogenesis inhibitors combined with radiation therapyCarsten Nieder, Nicole Wiedenmann, Nicolaus Andratschke, et al.
Anticancer Research|February 26, 2004
Radiotherapy-induced lung toxicity: risk factors and prevention strategiesCarsten Nieder, Branislav Jeremic, Sabrina Astner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2006
Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breastsCarsten Nieder, Sabine Schill, Peter Kneschaurek, et al.
Cell Stress & Chaperones|August 31, 2012
Radiosensitization of wildtype p53 cancer cells by the MDM2-inhibitor PXN727 is associated with altered heat shock protein 70 (Hsp70) levelsDaniela Schilling, Michael Düwel, Michael Molls, et al.
Anticancer Research|February 26, 2004
Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancerCarsten Nieder, Nicolaus Andratschke, Branislav Jeremic, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Necessity of identifying the patterns of failure after concurrent radiochemotherapy part of a combined modality approach in patients with stage III non-small cell lung cancer [Sakai et al., Lung Cancer 2004;43:195-201]Branislav Jeremic, Frank Zimmermann, Carsten Nieder, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2008
Validation of the graded prognostic assessment index for patients with brain metastasesCarsten Nieder, Kirsten Marienhagen, Hans Geinitz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2010
Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of preventionNicolaus Andratschke, Jean Maurer, Michael Molls, et al.
Critical Reviews in Oncology/Hematology|August 1, 2006
Therapeutic options for recurrent high-grade glioma in adult patients: recent advancesCarsten Nieder, Markus Adam, Michael Molls, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2002
Retreatment of the spinal cord with palliative radiotherapyAnca-Ligia Grosu, Nicolaus Andratschke, Carsten Nieder, et al.
Pageof 14